Ausgabe 5/2013
Inhalt (12 Artikel)
Could co-payments on drugs help to make EU health care systems less open to political influence?
Livio Garattini, Katelijne van de Vooren
Analysis of HIV/AIDS DRG in Portugal: a hierarchical finite mixture model
Sara Simões Dias, Valeska Andreozzi, Rosário O. Martins
Soft budget constraints in health care: evidence from Italy
Rosella Levaggi, Francesco Menoncin
Public preferences for establishing nephrology facilities in Greenland: estimating willingness-to-pay using a discrete choice experiment
Trine Kjær, Mickael Bech, Christian Kronborg, Morten Raun Mørkbak
Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia
Keith Tolley, Catherine Goad, Yunni Yi, Penny Maroudas, Amin Haiderali, Gwilym Thompson
Examining the determinants of drug launch delay in pre-TRIPS India
Saradindu Bhaduri, Thomas Brenner
Evaluating the redistributive impact of public health expenditure using an insurance value approach
Amedeo Spadaro, Lucia Mangiavacchi, Ignacio Moral-Arce, Marta Adiego-Estella, Angela Blanco-Moreno
The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop
Carla Guerriero, John Cairns, Ian Roberts, Anthony Rodgers, Robyn Whittaker, Caroline Free
Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study
Sarah Mostardt, Nikola Hanhoff, Jürgen Wasem, Armin Goetzenich, Knud Schewe, Eva Wolf, Christoph Mayr, Hans Jaeger, Holger Pfaff, Stephan Dupke, Anja Neumann
What determines health: a causal analysis using county level data
Andrew J. Rettenmaier, Zijun Wang
Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries
Christian Eckmann, Matthew Wasserman, Faisal Latif, Graeme Roberts, Axelle Beriot-Mathiot